Comparably Awards

Phathom is home to relentless trailblazers, disruptors, and builders. We are assembling the best and the brightest in the industry to usher in a new era of gastrointestinal (GI) care and we remain committed to transforming the treatment landscape for people suffering from GI diseases. read more

This company is accepting feedback from verified employees EMPLOYEE PARTICIPANTS: 83

TOTAL RATINGS: 2393

CEO: Steven Basta

Steven Basta Phathom Pharmaceuticals CEO Rating

Phathom Pharmaceuticals' CEO, Steven Basta, has 83 employee ratings and a score of 97/100, placing them in the Top 5% of similar size companies on Comparably with 201-500 Employees. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that females at Phathom Pharmaceuticals rate Steven Basta higher than males, giving the CEO a score of 97/100.

Last updated months ago.

Where This Score Ranks Phathom Pharmaceuticals' CEO Rating

TOP
5%
In the Top 5% of 2013 Similar Sized Companies on Comparably
?
Not enough ratings to compare against all size companies in Florham Park, NJ.
1st
1st place versus 1 competitors rated on Comparably

Nov

Mar

May

Jun

Nov

A+97 / 100

Jan

Phathom Pharmaceuticals CEO Steven Basta Bio

Mr. Basta has more than 25 years of leadership experience in the biopharmaceutical and medical device industry. Mr. Basta served as CEO of SaNOtize, a company that develops and commercializes anti-infective therapies since 2023. SaNOtize has recently launched novel nitric oxide-based topical infection products in the US. Prior to this role, he served as CEO of Mahana Therapeutics, a prescription digital therapeutic company which launched the first FDA-approved digital app treatment for irritable bowel syndrome and developed a novel digital therapy for tinnitus. He previously served as CEO of Menlo Therapeutics (now VYNE Therapeutics), AlterG, BioForm Medical and its successor Merz Aesthetics. During his tenure at BioForm Medical and later Merz Aesthetics Mr. Basta built a leading worldwide medical aesthetics business with industry-leading innovations in product design, new applications, and commercial strategies.

He currently serves on the board of directors of DermBiont, Inc. and VYNE Therapeutics.

Mr. Basta holds an MBA from the Kellogg Graduate School of Management at Northwestern University and a BA in Biomedical Engineering from Johns Hopkins University.

Who Ranks Phathom Pharmaceuticals' CEO Rating the Highest?

Ethnicity - African American/Black 100/100

Department - Marketing 99/100

Ethnicity - Asian or Pacific Islander 98/100

Who Ranks Phathom Pharmaceuticals' CEO Rating the Lowest?

Ethnicity - Hispanic or Latino 90/100

Department - Clinical & Medical Affairs 93/100

Ethnicity - Other 96/100

Phathom Pharmaceuticals CEO Steven Basta At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Phathom Pharmaceuticals.

Based on 83 ratings, Steven Basta ranks right above Ironwood Pharmaceuticals' CEO, Mark Mallon.

Phathom Pharmaceuticals' CEO is highly regarded by African American/Black employees, the Marketing department, and Asian or Pacific Islander employees. However, Hispanic or Latino employees and the Clinical & Medical Affairs department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.